Matches in Wikidata for { <http://www.wikidata.org/entity/Q65388651> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q65388651 description "clinical trial" @default.
- Q65388651 description "ensayu clínicu" @default.
- Q65388651 description "klinisch onderzoek" @default.
- Q65388651 description "клінічне випробування" @default.
- Q65388651 name "EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas" @default.
- Q65388651 name "EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas" @default.
- Q65388651 type Item @default.
- Q65388651 label "EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas" @default.
- Q65388651 label "EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas" @default.
- Q65388651 prefLabel "EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas" @default.
- Q65388651 prefLabel "EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas" @default.
- Q65388651 P1050 Q65388651-D88A10C4-58EF-4589-AE56-599449B54135 @default.
- Q65388651 P1132 Q65388651-844400AE-66C6-4385-B27D-5011A9930AE4 @default.
- Q65388651 P1476 Q65388651-9E1F7AB3-3522-4B0C-A8DB-BF2143E182F6 @default.
- Q65388651 P17 Q65388651-37F50CA9-323D-400B-850F-E244BA97E910 @default.
- Q65388651 P17 Q65388651-43363622-FE95-4684-A02A-3A47CB989977 @default.
- Q65388651 P17 Q65388651-85428564-20D5-4092-A6EE-D7D3D1E13E11 @default.
- Q65388651 P2899 Q65388651-5C581A35-2FCA-4463-ABB1-65EDA4605BCB @default.
- Q65388651 P3098 Q65388651-678A1BA6-6B44-4627-B1AE-6B5697B8C643 @default.
- Q65388651 P31 Q65388651-09F0E884-0C0F-4D59-80F6-38E1A69DF15A @default.
- Q65388651 P4844 Q65388651-496A3EDB-1833-4865-9D56-39E5D48B1CB6 @default.
- Q65388651 P580 Q65388651-6314974B-C675-4DC0-93C8-586F6A5866B2 @default.
- Q65388651 P582 Q65388651-3CE7135F-20ED-4EAF-86CE-198CF0FE77F1 @default.
- Q65388651 P6099 Q65388651-13A15BFF-D5D3-40A6-A792-067FE7F8D1CC @default.
- Q65388651 P8363 Q65388651-C090FDFE-C2E5-4B59-9B46-B3027AF796AC @default.
- Q65388651 P859 Q65388651-95C95582-5EF7-44A2-8722-385C0EFA082E @default.
- Q65388651 P1050 Q356033 @default.
- Q65388651 P1132 "+212" @default.
- Q65388651 P1476 "A Controlled, Randomized, Open Label Phase II Trial to Evaluate Safety and Efficacy of a 1st Line Combination Treatment With Weekly Infusions of Gemcitabine and Twice Weekly Administration of Lipid Complexed Paclitaxel (EndoTAG-1) in Three Dose Levels Compared With Gemcitabine Monotherapy in Patients With Measurable Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas" @default.
- Q65388651 P17 Q212 @default.
- Q65388651 P17 Q213 @default.
- Q65388651 P17 Q28 @default.
- Q65388651 P2899 "+18" @default.
- Q65388651 P3098 "NCT00377936" @default.
- Q65388651 P31 Q30612 @default.
- Q65388651 P4844 Q423762 @default.
- Q65388651 P580 "2005-09-01T00:00:00Z" @default.
- Q65388651 P582 "2008-06-01T00:00:00Z" @default.
- Q65388651 P6099 Q42824440 @default.
- Q65388651 P8363 Q78089383 @default.
- Q65388651 P859 Q1403929 @default.